2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Yariv D et al. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. 2010 Colloids Surf B Biointerfaces pmid:20363601
Costa-Balogh FO et al. Drug release from lipid liquid crystalline phases: relation with phase behavior. 2010 Drug Dev Ind Pharm pmid:19848561
Liu G et al. Colloidal amphiphile self-assembly particles composed of gadolinium oleate and myverol: evaluation as contrast agents for magnetic resonance imaging. 2010 Langmuir pmid:19852474
Trickler WJ et al. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. 2010 AAPS PharmSciTech pmid:20238190
Salentinig S et al. Self-assembled structures and pKa value of oleic acid in systems of biological relevance. 2010 Langmuir pmid:20578757
Mulet X et al. High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles. 2010 Int J Pharm pmid:20580796
Nguyen TH et al. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. 2010 J. Pharm. Pharmacol. pmid:20636872
Nguyen TH et al. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation. 2010 J. Pharm. Pharmacol. pmid:20636873
Gan L et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. 2010 Int J Pharm pmid:20558263
Cohen-Avrahami M et al. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. 2010 Colloids Surf B Biointerfaces pmid:20189781
Bitan-Cherbakovsky L et al. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C. 2010 Langmuir pmid:20175578
Fiehn O et al. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. 2010 PLoS ONE pmid:21170321
Meyre ME et al. Multilamellar liposomes entrapping aminosilane-modified maghemite nanoparticles: "magnetonions". 2010 Phys Chem Chem Phys pmid:20820553
Lif A et al. Fischer-Tropsch diesel emulsions stabilised by microfibrillated cellulose and nonionic surfactants. 2010 J Colloid Interface Sci pmid:20864117
Tang T et al. Determination of triazole fungicides in environmental water samples by high performance liquid chromatography with cloud point extraction using polyethylene glycol 600 monooleate. 2010 Anal. Chim. Acta pmid:20969987
Joseph JS et al. Characterization of lipid matrices for membrane protein crystallization by high-throughput small angle X-ray scattering. 2011 Methods pmid:21903166
Wallace E et al. Monoolein lipid phases as incorporation and enrichment materials for membrane protein crystallization. 2011 PLoS ONE pmid:21909395
Zhai J et al. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles. 2011 Langmuir pmid:22026367
Alam MM et al. Kinetics of low pH-induced lamellar to bicontinuous cubic phase transition in dioleoylphosphatidylserine∕monoolein. 2011 J Chem Phys pmid:21495771
Nguyen TH et al. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. 2011 J Control Release pmid:21497623